By Sharon Tasman Prysant | June 24, 2014 at 03:17 PM EDT | No Comments
As reported today in the India Economic Times, pharmaceutical companies having more than a 1% market share of "essential" drugs may find it difficult to exit the India market based on new rules from the National Pharmaceutical Pricing Authority. If a drug is on the National List of Essential Medicine, the pharma company will have to issue a public notice and alert the government at least 6 months in advance of discontinuing marketing of the drug in India. In addition, the government has the right to require production for an additional 1 year.
Read more at http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/pharmaceutical-firms-find-it-hard-to-exit-essential-drugs-market/articleshow/37104922.cms